TREATMENT OF POST-MENOPAUSAL ADVANCED BREAST CANCER- NETWORK META-ANALYSIS USING SECOND-ORDER FRACTIONAL POLYNOMIALS MODELS

Author(s)

Harvey R
DRG Abacus, Manchester, UK

OBJECTIVES: A multi-dimensional approach to evidence synthesis has previously been explored as an alternative to analysis of hazard ratios (HR) frequently used for time-to-event data. The objective of this study was to explore and compare results using a more complex approach to network meta-analysis (NMA) with those using conventional methods. The methods were applied to an evidence base previously identified to evaluate comparative efficacy for the treatment of advanced breast cancer in postmenopausal women following failure of prior endocrine therapy.

METHODS: Data were identified from a published systematic literature review previously conducted in this population; these data were synthesised within a Bayesian NMA utilising fractional polynomial models to estimate relative efficacy between different interventions for overall survival. Kaplan–Meier curves reported by all studies were digitised to recreate virtual individual patient data. Extrapolated long-term survival profiles, expected (mean) survival and ranking probabilities were also estimated for each intervention.

RESULTS: Seven trials were identified, which assesed seven comparators of interest. Fulvestrant 500 mg was found to be the most effective intervention; mean survival was over 3 years and there was around a 40% chance of fulvestrant 500 mg being ranked as the best treatment over a 10-year time horizon. Findings and trends were consistent with previously published NMAs utilising conventional methodology, synthesising HRs.

CONCLUSIONS: A comprehensive approach to evidence synthesis may yield more informative, robust and reliable estimates of comparative efficacy than traditional NMA methods analysing trial-level HRs. These efficacy estimates may subsequently be incorporated into cost-effectiveness models without the assumption of proportional hazards between treatment arms that underpins the use of HRs, which have been shown to be a limited measure of treatment effect. An alternative approach to synthesis, utilising fractional polynomials models, may lead to more informed decision-making, which is critical when there are budget constraints associated with reimbursement of new interventions.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PCN18

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×